investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Analyzing Suvretta Capital Management, LLC's Q3 2022 vs. Q4 2022 13F Holdings Comparison CSV: Significant Changes in Holdings Revealed

Ava Hoppe | 20 April, 2023

Suvretta Capital Management, LLC is an investment management firm that specializes in long-term investments in public equities. The firm's Q3 2022 vs. Q4 2022 13F Holdings Comparison CSV provides an interesting insight into the fund's changes in holdings during the third and fourth quarters of 2022.

The CSV contains information about the issuer name, option type, Q3 2022 shares, Q4 2022 shares, Q3 2022 value, Q4 2022 value, and percent change for each of the holdings. The holdings are grouped into categories such as healthcare, technology, and finance.

One of the most significant changes in holdings in the healthcare category was the increase in holdings of Horizon Therapeutics PubL by 125.6%. Suvretta Capital Management, LLC held 712,561 shares of the company in Q3 2022, which increased to 874,291 shares in Q4 2022. The value in Q3 2022 was $44,100, which increased to $99,494 in Q4 2022.

Another significant change in holdings is the increase in Kura Oncology Inc by 42.6%. Suvretta Capital Management, LLC held 4,063,128 shares of the company in Q3 2022, which increased to 6,376,815 shares in Q4 2022. The value in Q3 2022 was $55,502, which increased to $79,136 in Q4 2022.

Additionally, the CSV shows that Suvretta Capital Management, LLC added some new holdings during the fourth quarter of 2022, including Alvotech and Akili Inc. Alvotech is a biopharmaceutical company that focuses on developing biosimilars, while Akili Inc is a digital medicine company that develops video game-based treatments for patients with cognitive disorders.

However, the fund also decreased its holdings in some companies during the fourth quarter of 2022. For example, Suvretta Capital Management, LLC reduced its holdings in Meta Platforms Inc by 56.2%. The fund held 498,290 shares of the company in Q3 2022, which decreased to 246,259 shares in Q4 2022. The value in Q3 2022 was $67,608, which decreased to $29,634 in Q4 2022.

Another example of decreased holdings is Wynn Resorts Ltd, where the fund had no shares in Q3 2022, and it increased holdings to 685,001 shares in Q4 2022. The value in Q4 2022 was $56,492, but the overall change in holding percentage was -13.

In the finance category, Suvretta Capital Management, LLC decreased its holdings in AmerisourceBergen Corp by 55.3%. The fund held 341,779 shares of the company in Q3 2022, which decreased to 124,658 shares in Q4 2022. The value in Q3 2022 was $46,253, which decreased to $20,657 in Q4 2022.

Finally, the CSV shows that the fund increased its holdings in Canadian Pac Ry Ltd by 10.3%. Suvretta Capital Management, LLC held 776,276 shares in Q3 2022, which increased to 765,840 shares in Q4 2022. The value in Q3 2022 was $51,793, which increased to $57,124 in Q4 2022.

In conclusion, the Suvretta Capital Management, LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison CSV reveals significant changes in the fund's holdings, with increased holdings in some companies and decreased holdings in others. The changes reflect the fund's investment strategy, which is to build a portfolio of high-quality, growth-oriented companies with long-term potential. The fund's focus on healthcare, technology, and finance will continue to drive its investment decisions in the future.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.